Abstract:Most infectious agents affect or start from a mucosal surface, therefore mucosal immunization would be expected to be a promising method to efficiently induce local and systemic immunity against these infections. Since fish gill is a mucosal surface containing organized lymphoid structure, which is considered as a potential site for vaccination. Herein, we designed a novel biomimetic nanovaccine by encapsulating poly(D,L-lactide-co-glycolide)-based DNA vaccine with teleost erythrocytes membrane modified by mannose. Since all the materials used for the construction of PG@EM-M nanovaccine are fully biocompatible, PG@EM-M shown good biocompatibility in vivo and in vitro. Zebrafish, a model organism, were immunized with PG@EM-M nanovaccine via branchial route to evaluate the local and systemic immunity. As an environmentally and economically important rhabdovirus, spring viremia of carp virus (SVCV) was used as a model for virus challenge. Three SVCV challenge tests were carried out in zebrafish on 7th, 28th, and 70th day post vaccination, respectively. PG@EM-M vaccinated fish shown highest survival rate of ca.48%, ca.81%, and ca.62% on 7th, 28th, and 70th day post vaccination, respectively. In addition, the viral loads were significantly decreased (P < 0.01) in gill and spleen tissues after PG@EM-M vaccination, respectively. Owing to the specific interaction between mannose moiety with antigen presenting cells (APCs), as expected, PG@EM-M shown significantly enhanced of cellular uptake by APCs compared to PG@EM (without mannose modification). Interestingly, we found strong retention ability of PG@EM-M in the local immunization site (gill), and its migration to systemic immune tissues (spleen). Notably, this study demonstrated that PG@EM-M could induce robust mucosal and systemic immune response in vaccinated fish via the branchial route. This work presents a novel design of erythrocytes-mimic nanoparticles for mucosal immunization, which would be expected to increase the efficacy and improve the design of mucosal vaccines for aquaculture.

Application of Antigen Presenting Cell-Targeted Nanovaccine Delivery System in Rhabdovirus Disease Prophylactics Using Fish As a Model Organism

Targeted Delivery of Mannosylated Nanoparticles Improve Prophylactic Efficacy of Immersion Vaccine against Fish Viral Disease

Enhanced Protective Immunity Against Spring Viremia of Carp Virus Infection Can Be Induced by Recombinant Subunit Vaccine Conjugated to Single-Walled Carbon Nanotubes.

Application of Biomimetic Cell-Derived Nanoparticles with Mannose Modification as a Novel Vaccine Delivery Platform against Teleost Fish Viral Disease

Evaluation of Immune Response and Protection Against Spring Viremia of Carp Virus Induced by a Single-Walled Carbon Nanotubes-Based Immersion DNA Vaccine

Single-walled carbon nanotubes as delivery vehicles enhance the immunoprotective effects of a recombinant vaccine against Aeromonas hydrophila.

Mannose modified targeted immersion vaccine delivery system improves protective immunity against Infectious spleen and kidney necrosis virus in mandarin fish ( Siniperca chuatsi )

Carbon Nanotubes-Loaded Subunit Vaccine Can Increase Protective Immunity Against Rhabdovirus Infections of Largemouth Bass (micropterus Salmoides).

Immunopotentiation Mechanism of a Mannose-Modified Peptide Fragment Containing a Dominant Antigenic Epitope of Micropterus Salmoides Rhabdovirus (MSRV) Glycoprotein after Coupling to Nanocarrier

Single-walled Carbon Nanotubes As Delivery Vehicles Enhance the Immunoprotective Effect of a DNA Vaccine Against Spring Viremia of Carp Virus in Common Carp

Development and Evaluation of Self-Assembling Nanovaccine for Immune Protection Against Spring Viremia of Carp

Immune Response and Protective Effect Against Spring Viremia of Carp Virus Induced by Intramuscular Vaccination with a SWCNTs-DNA Vaccine Encoding Matrix Protein.

Single-walled Carbon Nanotubes As Candidate Recombinant Subunit Vaccine Carrier for Immunization of Grass Carp Against Grass Carp Reovirus.

Optimization of Immunization Procedure for SWCNTs-based Subunit Vaccine with Mannose Modification Against Spring Viraemia of Carp Virus in Common Carp

Protective Immunity Against Infectious Spleen and Kidney Necrosis Virus Induced by Mannose Modified Subunit Vaccine with Carbon Nanotubes in Mandarin Fish

Mucosal Delivery of Mannose Functionalized Biomimetic Nanoparticles Via the Branchial Route Induces Robust Mucosal and Systemic Immune Responses Against Fish Viral Disease

Dual-Targeting Polymer Nanoparticles Efficiently Deliver DNA Vaccine and Induce Robust Prophylactic Immunity against Spring Viremia of Carp Virus Infection

The Protective Immunity Against Grass Carp Reovirus in Grass Carp Induced by a DNA Vaccination Using Single-Walled Carbon Nanotubes As Delivery Vehicles

Immersion Vaccination of Mandarin Fish Siniperca Chuatsi Against Infectious Spleen and Kidney Necrosis Virus with a SWCNTs-based Subunit Vaccine

How modular protein nanoparticles may expand the ability of subunit anti-viral vaccines: The spring viremia carp virus (SVCV) case

The immunoprotective effect of whole-cell lysed inactivated vaccine with SWCNT as a carrier against Aeromonas hydrophila infection in grass carp.